Microorganism microneedle micro-engine depth drug delivery

As a transdermal drug delivery method, microneedles offer minimal invasiveness, painlessness, and precise in-situ treatment. However, current microneedles rely on passive diffusion, leading to uncontrollable drug penetration. To overcome this, we developed a pneumatic microneedle patch that uses live Enterobacter aerogenes as microengines to actively control drug delivery. These microbes generate gas, driving drugs into deeper tissues, with adjustable glucose concentration allowing precise control over the process. Our results showed that this microorganism-powered system increases drug delivery depth by over 200%, reaching up to 1000 μm below the skin. In a psoriasis animal model, the technology effectively delivered calcitriol into subcutaneous tissues, offering rapid symptom relief. This innovation addresses the limitations of conventional microneedles, enhancing drug efficiency, transdermal permeability, and introducing a creative paradigm for on-demand controlled drug delivery.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2024-10-17
DOI
https://doi.org/10.1038/s41467-024-53280-8
Citations
64
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
13.31

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Microorganism microneedle micro-engine depth drug delivery

Yang Bai, Yanhong Duo, Laiping Fang, Boxi Shen et al.
64 citations
Nature Communications
Advancements in Transdermal Drug Delivery
13.31
article

Microorganism microneedle micro-engine depth drug delivery

Yang Bai, Yanhong Duo, Laiping Fang, Boxi Shen, Bin Zheng, Shixiang Cheng, Xingcai Zhang, Xiaolu Cai, Yan Liu, Zhengyu Wu, Qiuya Li, Bowen Li
article en
64 citations

Abstract

As a transdermal drug delivery method, microneedles offer minimal invasiveness, painlessness, and precise in-situ treatment. However, current microneedles rely on passive diffusion, leading to uncontrollable drug penetration. To overcome this, we developed a pneumatic microneedle patch that uses live Enterobacter aerogenes as microengines to actively control drug delivery. These microbes generate gas, driving drugs into deeper tissues, with adjustable glucose concentration allowing precise control over the process. Our results showed that this microorganism-powered system increases drug delivery depth by over 200%, reaching up to 1000 μm below the skin. In a psoriasis animal model, the technology effectively delivered calcitriol into subcutaneous tissues, offering rapid symptom relief. This innovation addresses the limitations of conventional microneedles, enhancing drug efficiency, transdermal permeability, and introducing a creative paradigm for on-demand controlled drug delivery.

Nature CommunicationsVol. 15(1)
Harvard University (US), Jinan University (CN), Tianjin University (CN), Tianjin Medical University General Hospital (CN), Tianjin Economic-Technological Development Area (CN), Tianjin Stomatological Hospital (CN), Stanford Medicine (US), Guangdong Provincial People's Hospital (CN), Huazhong University of Science and Technology (CN), Tianjin Medical University (CN), Stanford University (US)
National Natural Science Foundation of China, Natural Science Foundation of Tianjin City, National Key Research and Development Program of China
Zero hunger
Openalex Percentile: Top 1%
Advancements in Transdermal Drug Delivery
13.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.